Literature DB >> 17396274

Leishmaniasis.

Tonio V Piscopo1, Charles Mallia Azzopardi.   

Abstract

Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease compared with other infections, climate change and its possible impact on extension of endemicity of this infection, and new diagnostic tests which are improving diagnosis, especially in resource poor areas. Other important aspects discussed include the potential for newer oral therapy to change the way this disease is managed; Leishmania-HIV coinfection and groups at risk; and development of an effective vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396274      PMCID: PMC3202701          DOI: 10.1136/pgmj.2006.047340corr1

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  81 in total

1.  Positive Montenegro skin test among patients with sporotrichosis in Rio De Janeiro.

Authors:  Mônica Bastos de Lima Barros; Armando Schubach; Antônio Carlos Francesconi-do-Valle; Maria Clara Gutierrez-Galhardo; Tânia Maria Pacheco Schubach; Fátima Conceição-Silva; Mariza de Matos Salgueiro; Eliame Mouta-Confort; Rosani Santos Reis; Maria de Fátima Madeira; Tullia Cuzzi; Leonardo Pereira Quintella; Janaína Pinho da Silva Passos; Maria José Conceição; Mauro Célio de Almeida Marzochi
Journal:  Acta Trop       Date:  2005-01       Impact factor: 3.112

2.  Kala-azar (visceral leishmaniasis): report of a case with 34 month incubation period and positive Doan-Wright test.

Authors:  H H STONE; C D TOOL; W S PUGSLEY
Journal:  Ann Intern Med       Date:  1952-02       Impact factor: 25.391

3.  Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India.

Authors:  T K Jha; P Olliaro; C P Thakur; T P Kanyok; B L Singhania; I J Singh; N K Singh; S Akhoury; S Jha
Journal:  BMJ       Date:  1998-04-18

4.  Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis.

Authors:  S Sundar; S G Reed; S Sharma; A Mehrotra; H W Murray
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

Review 5.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.

Authors:  F Laguna; R López-Vélez; F Pulido; A Salas; J Torre-Cisneros; E Torres; F J Medrano; J Sanz; G Picó; J Gómez-Rodrigo; J Pasquau; J Alvar
Journal:  AIDS       Date:  1999-06-18       Impact factor: 4.177

7.  Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.

Authors:  F Pasquau; J Ena; R Sanchez; J M Cuadrado; C Amador; J Flores; C Benito; C Redondo; J Lacruz; V Abril; J Onofre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

8.  Simplified polymerase chain reaction detection of new world Leishmania in clinical specimens of cutaneous leishmaniasis.

Authors:  A Belli; B Rodriguez; H Aviles; E Harris
Journal:  Am J Trop Med Hyg       Date:  1998-01       Impact factor: 2.345

Review 9.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

10.  Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection.

Authors:  Herbert Sindermann; Kirsten R Engel; Christina Fischer; Wolfgang Bommer
Journal:  Clin Infect Dis       Date:  2004-10-18       Impact factor: 9.079

View more
  39 in total

1.  The economic value of a visceral leishmaniasis vaccine in Bihar state, India.

Authors:  Bruce Y Lee; Kristina M Bacon; Mirat Shah; Sara Beth Kitchen; Diana L Connor; Rachel B Slayton
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Epidemiology of Cutaneous Leishmaniasis in a Colombian Municipality.

Authors:  Diego Alejandro Medina-Morales; Manuel E Machado-Duque; Jorge Enrique Machado-Alba
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

3.  Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction.

Authors:  Michelle A Favila; Nicholas S Geraci; Erliang Zeng; Brent Harker; David Condon; Rachel N Cotton; Asha Jayakumar; Vinita Tripathi; Mary Ann McDowell
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

4.  [Kala azar - Lethal course of visceral leishmaniasis. Synchronous infection with Leishmania donovani/infantum complex and Leishmania major in a patient after Mediterranean vacation].

Authors:  C Posch; J Walochnik; A Gschnait; H Feichtinger; K Rappersberger
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

5.  Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds.

Authors:  Jair L Siqueira-Neto; Ok-Ryul Song; Hyunrim Oh; Jeong-Hun Sohn; Gyongseon Yang; Jiyoun Nam; Jiyeon Jang; Jonathan Cechetto; Chang Bok Lee; Seunghyun Moon; Auguste Genovesio; Eric Chatelain; Thierry Christophe; Lucio H Freitas-Junior
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

6.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

Review 7.  Studies on protozoa in ancient remains--a review.

Authors:  Liesbeth Frías; Daniela Leles; Adauto Araújo
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

8.  Recombinant C-Reactive Protein: A Potential Candidate for the Treatment of Cutaneous Leishmaniasis of BALB/c Mice Caused by Leishmania major.

Authors:  Seyedeh Noushin Zahedi; Seyed Hossein Hejazi; Maryam Boshtam; Farahnaz Amini; Hossein Fazeli; Mahdieh Sarmadi; Mahsa Rahimi; Hossein Khanahmad
Journal:  Acta Parasitol       Date:  2020-07-16       Impact factor: 1.440

Review 9.  Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

Authors:  Lucio H Freitas-Junior; Eric Chatelain; Helena Andrade Kim; Jair L Siqueira-Neto
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-28       Impact factor: 4.077

10.  Temporal lagged relationship between a vegetation index and cutaneous leishmaniasis cases in Colombia: an analysis implementing a distributed lag nonlinear model.

Authors:  Juan David Gutiérrez-Torres
Journal:  Parasitol Res       Date:  2020-01-03       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.